Anzeige
Mehr »
Login
Freitag, 29.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3DMQ2 | ISIN: KYG7S53R1049 | Ticker-Symbol:
NASDAQ
28.03.24
20:37 Uhr
1,605 US-Dollar
+0,035
+2,23 %
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
PROKIDNEY CORP Chart 1 Jahr
5-Tage-Chart
PROKIDNEY CORP 5-Tage-Chart

Aktuelle News zur PROKIDNEY Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoPROKIDNEY CORP. - 8-K, Current Report1
MoProKidney boosts leadership for phase 3 program clinical program1
MoProKidney Announces Key Leadership Appointments Strengthening Clinical and Technical Operations73Dr. Ulrich Ernst joins as Executive Vice President of Technical Operations with a deep background and expertise in process development and manufacturing of cell therapies Mr. Lucio Tozzi joined in...
► Artikel lesen
22.03.PROKIDNEY CORP. - S-8, Securities to be offered to employees in employee benefit plans1
22.03.ProKidney GAAP EPS of -$0.57 beats by $0.081
22.03.ProKidney Reports Full Year 2023 Financial Results and Recent Corporate Highlights99WINSTON-SALEM, N.C., March 21, 2024 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ("ProKidney" or the "Company"), a leading late clinical-stage cellular therapeutics company focused on chronic...
► Artikel lesen
07.03.Morgan Stanley starts ProKidney stock coverage, focus on new therapy 'REACT'2
12.02.PROKIDNEY CORP. - 8-K, Current Report1
19.01.PROKIDNEY CORP. - 8-K, Current Report1
30.11.23PROKIDNEY CORP. - 8-K, Current Report-
30.11.23ProKidney Appoints Nikhil Pereira-Kamath, MBA, as Chief Business Officer1
21.11.23ProKidney former 10% owner Chamath Palihapitiya discloses sale of over 7M shares1
21.11.23ProKidney to Participate in a Fireside Chat at the Upcoming Evercore ISI 6th Annual HEALTHCONx Conference1
17.11.23ProKidney Corp. (PROK) Q3 2023 Earnings Call Transcript1
14.11.23ProKidney amends Phase III protocol in light of Phase II results3
14.11.23ProKidney reports higher Q3 loss, strong cash position1
14.11.23ProKidney GAAP EPS of -$0.181
14.11.23ProKidney Reports Third Quarter Financial Results211WINSTON-SALEM, N.C., Nov. 14, 2023 (GLOBE NEWSWIRE) -- ProKidney Corp. (Nasdaq: PROK) ("ProKidney"), a leading late clinical-stage cellular therapeutics company focused on chronic kidney disease (CKD)...
► Artikel lesen
14.11.23ProKidney appoints new CEO, updates Phase 3 plans for REACT therapy1
13.11.23PROKIDNEY CORP. - 8-K, Current Report1
Seite:  Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1